EndoArt to launch hip endoprosthesis plant in St. Petersburg

EndoArt, a subsidiary of BSS pharmaceutical holding, is launching a plant in St. Petersburg for cemented and cementless hip endoprostheses. The project required 1 billion rubles in investment, with capacity for up to 35,000 units annually. The plant is set to launch in August 2024.

“The EndoArt company, a subsidiary of the BSS pharmaceutical holding, is gearing up to launch a plant for the production of cemented and cementless hip endoprostheses.”gxpnews.net

• 1 source
• gxpnews.net1 Billion Rubles Invested in New Endoprosthesis Production Facility in St. Petersburg | News | GxP NewsОт GxP NewsJul 31, 2024

Summarized from public sources; check the original articles before acting on it.